Scott Eggener

Featured in: Favicon

nytimes.com Favicon

springer.com Favicon

khaleejtimes.com Favicon

acpjournals.org Favicon

rsn.org

europeanurology.com Favicon

urotoday.com Favicon

saludconlupa.com Favicon

link.springer.com

Articles

Leveraging Cutting-Edge Technologies to Enhance Prostate Cancer Treatments "Presentation" - Scott Eggener

Nov 20, 2024 | urotoday.com | Scott Eggener

Read the Full Video TranscriptGordon: I have the distinct pleasure of inviting Dr. Eggener to the podium to give us a discussion around leveraging cutting-edge technologies in the management of prostate cancer patient treatment options. He's the professor of urology at the University of Chicago School of Medicine, the vice chair, Section of Urology, and he currently is the director of High Risk and Advanced Prostate Cancer, a prolific academic surgeon, and an all-around great human being.
Welcome and Background Cancer or Not Cancer "Presentation" - Scott Eggener

Jul 24, 2024 | urotoday.com | Scott Eggener

Read the Full Video TranscriptScott Eggener: The public health would be improved if Grade Group 1 was no longer called cancer. And we've tacitly been moving in that direction. There's a whole bunch of biomarkers that look not to diagnose Grade Group 1; that's the main attraction, it's one of the main attractions of MRI.
Welcome and Background for This Meeting "Presentation" - Scott Eggener

Jul 23, 2024 | urotoday.com | Scott Eggener

Read the Full Video TranscriptScott Eggener: The public health would be improved if Grade Group 1 was no longer called cancer. And we've tacitly been moving in that direction. There's a whole bunch of biomarkers that look not to diagnose Grade Group 1; that's the main attraction, it's one of the main attractions of MRI.
No todo lo que denominamos cáncer debe ser llamado así

Sep 26, 2023 | saludconlupa.com | Laura Esserman |Scott Eggener

“Tienes cáncer”. Puedes preguntárselo a cualquiera que le hayan dicho eso: es aterrador. Esa es una de las razones por las que debemos replantearnos lo que llamamos cáncer.
Not everything we call cancer should be called cancer

Sep 5, 2023 | khaleejtimes.com | Laura Esserman |Scott Eggener

Not everything we call cancer should be called cancer Calling something cancer can lead to aggressive treatment even if the cancer in question is unlikely to cause problems.
Pre-Cancer- OverDiagnoses, OverTreatment?

Sep 4, 2023 | peoplebeatingcancer.org | David Emerson |Scott Eggener

Dr. Esserman is a surgeon and breast cancer oncologist at the University of California, San Francisco. Dr. Eggener is a surgeon and urologic oncologist at the University of Chicago. “You Have Cancer.” Ask anyone who has been told this: It’s terrifying. That’s one reason we need to rethink what we call cancer. Despite amazing advances in our understanding of the disease, we have neglected to update how we define what has been called the emperor of all maladies.
Not Everything We Call Cancer Should Be Called Cancer

Aug 30, 2023 | nytimes.com | Laura Esserman |Scott Eggener

Laura Esserman and "You have cancer."Ask anyone who has been told this: It's terrifying. That's one reason we need to rethink what we call cancer. Despite amazing advances in our understanding of the disease, we have neglected to update how we define what has been called the emperor of all maladies. Some cancers have extraordinarily low risks of altering the quality or length of life but get lumped in with those that do.
The Emotional Toll of Surgical Complications - Scott Eggener

Aug 1, 2023 | urotoday.com | Scott Eggener

Read the Full Video TranscriptZach Klaassen: Hi, my name is Dr. Zach Klaassen. I'm a urologic oncologist at the Georgia Cancer Center in Augusta, Georgia. Thank you for joining us for this UroToday discussion with Dr. Scott Eggener who is a Professor of Urology at the University of Chicago. Dr. Eggener, thanks so much for joining us today. Scott Eggener: Yeah, thanks for having me, Dr. Klaassen. Zach Klaassen: Awesome.